Literature DB >> 19298636

Hepatitis antibody profile of Royal Thai Army nursing students.

Chaiyaphruk Pilakasiri1, Robert V Gibbons, Richard G Jarman, Somjai Supyapoung, Khin Saw Aye Myint.   

Abstract

We report on a viral hepatitis serosurvey done on 381 nursing students in Bangkok; 360 (94%) were female. The mean age was 20 (+/-3.6) years (range 16-41 years); 143, 92, 86 and 59 students came from Thailand's Central, North, Northeast and South provinces, respectively. The overall prevalence of hepatitis A, B, C and E antibody in the students was 8.9%, 10.8%, 0.5% and 11.5%, respectively. The highest seroprevalence to hepatitis A was observed in cadets from the southern region of Thailand. Seroprevalence rates to hepatitis A and B were less than in other reported studies in Thailand.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298636     DOI: 10.1111/j.1365-3156.2009.02264.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  4 in total

1.  Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan.

Authors:  Sobia Attaullah; Sanaullah Khan; Sultan Ayaz; Shahid Niaz Khan; Ijaz Ali; Naseruddin Hoti; Sami Siraj
Journal:  Virol J       Date:  2011-06-06       Impact factor: 4.099

2.  Pork consumption and seroprevalence of hepatitis E virus,Thailand, 2007-2008.

Authors:  Siriphan Gonwong; Thippawan Chuenchitra; Patchariya Khantapura; Dilara Islam; Narongrid Sirisopana; Carl J Mason
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

3.  Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran.

Authors:  Hossein Saneian; Hamid Rahimi; Parisa Shoaei
Journal:  Int J Prev Med       Date:  2014-12

4.  Seroprevalence and incidence of hepatitis A in Southeast Asia: A systematic review.

Authors:  Gustavo Hernandez-Suarez; Debasish Saha; Kris Lodroño; Phatu Boonmahittisut; Stephanus Taniwijaya; Ashwini Saha; Selim Badur; Yong Poovorawan
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.